Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-12-07Clinical Trial Update: Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.
A survey-based clinical trial completed by AstraZeneca to describe how gastroesophageal reflux disease affects daily life before and after f…
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments
A completed AstraZeneca clinical trial examining how Swiss general practitioners segment GERD patients into three distinct groups.
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: Drug Interaction Study Between AZD3355 and Nexium [Phase 1]
The Phase 1 drug interaction study of AZD3355 with Nexium in gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: Study to Compare Different Formulations of AZD3355 [Phase 1]
An update on a Phase 1 study comparing different formulations of AZD3355 for gastroesophageal reflux disease. The trial has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD) [Phase 3]
A Phase 3 study evaluating the efficacy and safety of on-demand rabeprazole maintenance therapy for non-erosive reflux disease has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-11-23FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Omeprazole from Sandoz Inc, granting approval for this generic proton pump inhibitor under an AN…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients [Phase 3]
Phase 3 clinical trial update reporting safety data for daily esomeprazole in pediatric and adolescent patients with gastroesophageal reflux…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Esomeprazole for Treatment of GERD in Pediatric Patients [Phase 4]
Phase 4 trial update on esomeprazole for treating gastroesophageal reflux disease and associated esophagitis in pediatric patients has compl…
-
FDA approval · 2010-11-18FDA Approved: REGLAN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for REGLAN (metoclopramide hydrochloride) from ANI Pharmaceuticals, representing an approved regulat…
-
FDA approval · 2010-11-17FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for the generic omeprazole from Lannett Company, Inc., authorizing continued marketing under the…
-
FDA approval · 2010-10-29FDA Approved: FAMOTIDINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for famotidine from Dr. Reddy's Laboratories Limited, authorizing a modification to an existing …
-
CLINICAL_TRIALS trial_result · 2010-10-29Clinical Trial Update: Conventional Nissen Fundoplication Versus Laparoscopic Nissen Fundoplication [NA]
A completed clinical trial comparing conventional open Nissen fundoplication to laparoscopic Nissen fundoplication for Gastroesophageal refl…
-
FDA approval · 2010-10-27FDA Approved: RANITIDINE — Supplemental Application (Pharmaceutical Associates, Inc.)
The FDA approved a supplemental application for ranitidine submitted by Pharmaceutical Associates, Inc. The approval updates the product's e…
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: Diagnosis and Response to Treatment Using a Reliable Gastroesophageal Reflux Disease (GERD) Questionnaire: An In Clinical Practice Study
A completed clinical study evaluating a GERD questionnaire for diagnosing and monitoring response to treatment in gastroesophageal reflux di…
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Waist Circumference Versus Body Mass Index to Predict Severity of Gastroesophageal Reflux Disease
A completed clinical trial evaluated whether waist circumference or body mass index better predicts the severity of gastroesophageal reflux …
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Endoscopic Findings in Patients With Typical Gastroesophageal Reflux Disease (GERD) Symptoms
The update summarizes endoscopic findings from a completed clinical trial in patients with typical gastroesophageal reflux disease symptoms.
-
CLINICAL_TRIALS trial_result · 2010-10-05Clinical Trial Update: Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease [Phase 1]
Phase 1 study assessing the pharmacokinetics and safety of dexlansoprazole in adolescents with gastroesophageal reflux disease.
-
CLINICAL_TRIALS trial_result · 2010-09-24Clinical Trial Update: Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects [Phase 2]
This Phase 2 trial compared the antisecretory effect of a single 20 mg dose of rabeprazole versus 20 mg omeprazole in obese adults with gast…
-
CLINICAL_TRIALS trial_result · 2010-09-24Clinical Trial Update: Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)
A completed clinical trial (PULS) assessed the efficacy of pantoprazole in patients older than 12 with reflux-associated sleep disorders, in…
-
CLINICAL_TRIALS trial_result · 2010-09-24Clinical Trial Update: Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease
This clinical trial update reports the efficacy of pantoprazole 20/40 mg once daily in patients aged 12 years and older with gastroesophagea…
-
CLINICAL_TRIALS trial_result · 2010-09-22Clinical Trial Update: Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease [NA]
Completed clinical trial evaluating the association between nasal polyps and extraesophageal reflux disease; results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)
Completed clinical trial assessing the efficacy of pantoprazole in patients over 12 with non-erosive reflux disease or erosive GERD.
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders
This clinical trial update summarizes a completed study of pantoprazole 20/40 mg for symptomatic reflux disease, with a focus on sleep disor…
-
FDA approval · 2010-09-03FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) from Wyeth Pharmaceuticals LLC (a Pfizer subs…
-
FDA approval · 2010-09-03FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Dexilant (dexlansoprazole) filed by Takeda Pharmaceuticals America, Inc.